Blue Horseshoe Stocks: More Bottom-Plays

Seres Therapeutics, Inc. MCRB 

It was a pretty slow start to the week yesterday with the markets gapping up early, but falling into decline throughout the session. That didn’t stop the one fresh idea we did have in our morning report from posting a respectable performance on the day.

We referred to MCRB as a ‘prime bottom play’ and while it didn’t exactly explode out of the gate, what we did see was certainly a step in the right direction. From a low of 2.63, the stock ran a modest but solid 16% to a high of 3.06. More importantly, it preserved its momentum by holding the three-dollar mark into the close. A good first day by any stretch of the imagination.

We’ll continue to monitor our longer term options idea that we included, the MCRB 07/19 $2.50 Calls which stand to do well in coming weeks if the stock can continue to maintain the current trend. Yesterday’s session was the fourth consecutive day that the stock has recorded higher lows, and we’ll want to see more of that moving forward.


Verastem Inc. VSTM 

Speaking of bottom plays, we’ve got another one to add to our radars this morning in VSTM. This stock has lost a ton of value over the past year, and recently began to show signs of a rebound. We like it for its technical setup and volatility potential. We will remain interested in tracking VSTM for as long as it can maintain support at 1.72 or better.

VSTM is considered by some to be a speculative buyout play as well. Just this week the company has reported positive early stage data on Copiktra, the company’s leukemia treatment under development. Definitely an interesting story to follow.

____

Celestica Inc. CLS

Perhaps even more attractive as a bottom play than the above mentioned stock, we’ve got CLS, which just began to show signs of life after recording a new annual low at the beginning of this month.

If the stock can manage to break its 50DMA at 7.09, there’s a real chance that it could produce significant gains, filling the gap to the topside on the chart. Interesting to naote about CLS as well, is that the company’s EPS has grown by nearly 90% over the past year. When taking that into consideration, its current valuation doesn’t make a whole lot of sense.


Extended Watchlist:
CBAY, DERM, SAVA, NERV, NDRA, PHUN, VIVE

Blue Horseshoe Stocks: FAST Recap & More

Fastenal, Inc. FAST

Our fresh options ideas for yesterday morning was regarding Fastenal,which had just posted a solid Q1 earnings beat. The potential targets that we highlighted were the FAST 04/18 $62.50-67.50 Calls, and we’re happy to report that the stock’s activity has allowed us to see some decent moves out of those so far, with five sessions remaining until their expiration.

The moves was observed yesterday were as follows:

$50 Calls – Range: 5.40-6.50 – Max Gain: 20%
$52.50 Calls – Range: 2.40-4.30  – Max Gain: 79%
$55 Calls – Range: 1.10-2.08 – Max Gain: 89%

With the markets heating up here in the premarket, we’ll want to continue to keep an eye on FAST for the possibility of further useful activity that could propel these contracts to more gains before their expiration next Thursday.
____

FRESH OPTIONS IDEAS:
The Walt Disney Co. DIS Weekly $122-125 Calls
SPDR S&P500 ETF (SPY) Weekly $289-290 Calls

*Don’t trade weekly options on a Friday unless you’re an advanced level trader with disposable funds!


Extended Watchlist:
BPTH, WPX, JCP, BSMX, CBAY, WPX, ENDP

Blue Horseshoe Stocks: Fresh Options Ideas & More

OPTIONS UPDATES

Activision Blizzard. Inc. ATVI – To follow up with our idea from Wednesday morning in our premarket report, the ATVI Weekly $42-43.50 Calls, we wanted to provide one more update after another big move from the stock pushed our highlighted targets to new highs yesterday, and registered a really impressive two-day swing.

The following moves are the overall increases from the lows we observed on Wednesday: 

$42 Calls - 1.32-4.50 (+241%)
$42.50 Calls - .98-4.00 (+308%)
$43 Calls - .70-3.50 (+400%)
$43.50 Calls -  .44-3.05 (+593%)

Today, we are going to turn our attention to a slightly higher strike area, the ATVI Weekly $44.50-46 Calls*.
____

AstraZeneca plc AZN – The AZN Weekly $38-39.50 Calls  were on our radar yesterday morning as our fresh options idea, and despite the lower end of that range being pushed too far in the money, we still saw some solid moves out of the $39′s and $39.50′s.

The $39′s ran from .55-.90 for a gain of 64%, while the $39.50′s cruised from a low of .19 to hit .55; a big-time intraday pop of 189%  We want to continue to watching this chain as well, with the 39.50′s, and also rolling up to include the $40 and $40.50′s*.
____

FRESH IDEAS:

SPY Weekly $274.50-276 Calls*
CGC Weekly $46.50-48 Calls*
EA Weekly $107-109 Calls*
____

*Trading Weekly contracts on Friday should not be attempted unless you are an expert level trader with disposable funds.


Invacare Corp. IVC – Recap

Also appearing in yesterday’s report, was IVC, which we tagged in our extended watchlist. The stock made a good move on the day, which warrants further observation in coming sessions.

From a low of 7.21 IVC reached 9.54, which was good for an intraday rise of 32% which made it the second highest gainer on the NASDAQ for Thursday. We’ll continue to monitor this one as well.


Extended Watchlist:
ARSN, CBAY, SLDB, ICON, NGL, ADMA

Blue Horseshoe Stocks: BABA Review & More

Alibaba Group Holding Ltd. BABA – Update

After noticing a strong double-bottom setup on the chart, we threw our hat in the ring with BABA yesterday morning by formulating an options idea to track during what we described as an overdue recovery.

The stock did exhibit the first signs of that recovery, thereby producing some nice single-session gain opportunities for ourselves and our readers. Our targeted options were the BABA 05/04 $180-187.50 Calls, and regardless of the strike price chosen within our designated range, notable able intraday profits were there for the taking.

$180 Calls – Range: 3.60-5.10  – Max Gain: 42%
$182.50 Calls – Range: 2.80-3.75 – Max Gain: 34%
$185 Calls – Range: 2.21-3.05 – Max Gain: 38%
$187.50 Calls – Range: 1.74-2.27 – Max Gain: 30%

There is, of course, plenty of time before these contracts expire, so we’ll continue monitor these ideas going forward in the event that BABA stock continues its rebounding ways. Further opportunities may arise and we’ll want to be ready.


Tandem Diabetes Care, Inc. TNDM – Update

We also wanted to update everyone on another longer term idea we formulated that has definitely worked out in our favor. We’ve had a number of stocks that we signaled our interest in earlier in 2018 slowly and steadily make monster moves for us, and TNDM is the latest one.

We initially slated this play for observation In mid-January, and after only a slight consolidation at the beginning of February, the stock established support at a low of 2.14, reversed, and began a really impressive bull run that was amplified by a significant degree yesterday. TNDM ran to a new high of 7.22. That works out to a 237% increase here in the early goings of the 2018 calendar year.


Extended Watchlist:
PVG, CRIS, EYEG, CBAY, PRPO

Blue Horseshoe Stocks: More Options Ideas

BioMarin Pharmaceutical, Inc. BMRN

BioMarin had a really solid performance yesterday after we signaled some contracts in our premarket report, the BMRN 03/16 $80 & 85 Calls. The stock ran from 81.01 to 84.19 facilitating some modest but solid intraday moves in our contracts.

The $80 Calls ran from 4.40-6.00 for a 32% rise, and the $85′s traded from 2.70-3.50, a gain of 26%

With a strong close at 83.28, and a lot of ground to cover to recoup the losses the stock has seen in the month of February, we’ll look for BMRN to establish a more sustained recovery pattern, and we may see some further increases in these contracts, which still have over a month until expiration.


Under Armour, Inc. UAA

We want to formulate an idea for Under Armour on the heels of the company’s earnings report this morning. The stock had already begun to trend off of its bottom a few sessions ago, and despite posting a Q4 loss, sales were better than expected and the stock is gapping up pretty significantly here in the premarket.

We’re going to want to keep tabs on the UAA Weekly $15.50-16.50 Calls, which could bring us sizable gain opportunities in the day or days to come.


Extended Watchlist:
APRI, CHGG, CBAY, MVIS, ADXS, MBRX, DCIX, THC